PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
113 hedge funds and large institutions have $176M invested in Provention Bio, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 26 increasing their positions, 37 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
30% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 37
Holders
113
Holding in Top 10
–
Calls
$8M
Puts
$1.61M
Top Buyers
| 1 | +$8.19M | |
| 2 | +$5.19M | |
| 3 | +$1.5M | |
| 4 |
SC
Sessa Capital
New York
|
+$765K |
| 5 |
Morgan Stanley
New York
|
+$653K |
Top Sellers
| 1 | -$3.07M | |
| 2 | -$2.97M | |
| 3 | -$1.15M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.01M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$848K |